News
Real estate investment trusts are hoping to bounce back from a rough, and somewhat puzzling, reversal of fortunes in 2015, though investors are already lining up to support companies dealing in healthcare deals.
Valeant Pharmaceuticals International is now searching for a new chief executive officer, having told current CEO Mike Pearson over the weekend that he is no longer in the company's long-term plans. Pearson will continue to serve as CEO and a director until his replacement is appointed.
The Marcus Foundation has awarded a $75 million gift to Piedmont Healthcare to bolster the growth of Piedmont Heart Institute, their well-known heart and vascular program, the system announced Friday. Additionally, the large monetary gift will facilitate the renewal of Piedmont's Atlanta campus through the establishment of the Marcus Heart and Vascular Center.
Northwell CEO Michael Dowling led his team through an exhaustive rebranding process that pushed the system's marketing muscle and leaned on the past experiences of other major system rebrandings.
Under a proposed rule, different methods would be tried in selected geographic areas over a five-year test period. Some of these experiments would begin this year, with others added in 2017. The proposal faces two months of public comment.
California's insurance exchange is threatening to cut hospitals from its networks for poor performance or high costs, a novel proposal that is drawing heavy fire from medical providers and insurers.
The Supreme Court has sided with Liberty Mutual Insurance and against the state of Vermont in a decision that could have implications for insurers nationwide.
More consumers across all demographics are using alternative sites of care, including retail health clinics, urgent care centers and telehealth, according to a new online survey by management consulting firm Oliver Wyman. And many of those consumers are having good experiences.
Each year, a large portion of healthcare spending is on services for which consumers could price-shop ahead of time, a new study finds, suggesting that price transparency is an important factor in cutting down on healthcare costs.
The California Institute of Regenerative Medicine has awarded Tracy C. Grikscheit, MD, of The Saban Research Institute of Children's Hospital Los Angeles a $7.1 million grant to develop a cellular therapy for the treatment of digestive system nerve disorders, the hospital announced in a statement. The grant was awarded through CIRM's Translational Research Program.